Predicting Recovery of Cognitive Function Soon after Stroke: Differential Modeling of Logarithmic and Linear Regression

por Suzuki, Makoto, Sugimura, Yuko, Yamada, Sumio, Omori, Yoshitsugu, Miyamoto, Masaaki, Yamamoto, Jun-ichi
Publicado 2013

The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes

por Kubota, Yoshiaki, Miyamoto, Masaaki, Takagi, Gen, Ikeda, Takeshi, Kirinoki-Ichikawa, Sonoko, Tanaka, Kotoko, Mizuno, Kyoichi
Publicado 2012

The Effect of Control-released Basic Fibroblast Growth Factor in Wound Healing: Histological Analyses and Clinical Application

por Matsumoto, Shigeru, Tanaka, Rica, Okada, Kayoko, Arita, Kayo, Hyakusoku, Hiko, Miyamoto, Masaaki, Tabata, Yasuhiko, Mizuno, Hiroshi
Publicado 2013

PKN1 promotes synapse maturation by inhibiting mGluR-dependent silencing through neuronal glutamate transporter activation

por Yasuda, Hiroki, Yamamoto, Hikaru, Hanamura, Kenji, Mehruba, Mona, Kawamata, Toshio, Morisaki, Hiromi, Miyamoto, Masaaki, Takada, Shinji, Shirao, Tomoaki, Ono, Yoshitaka, Mukai, Hideyuki
Publicado 2020

Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale

por Kubota, Yoshiaki, Yamamoto, Takeshi, Tara, Shuhei, Tokita, Yukichi, Yodogawa, Kenji, Iwasaki, Yuki, Takano, Hitoshi, Tsukada, Yayoi, Asai, Kuniya, Miyamoto, Masaaki, Miyauchi, Yasushi, Kodani, Eitaro, Sato, Naoki, Tanabe, Jun, Shimizu, Wataru
Publicado 2018

Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus

por Hoshika, Yu, Kubota, Yoshiaki, Mozawa, Kosuke, Tara, Shuhei, Tokita, Yukichi, Yodogawa, Kenji, Iwasaki, Yu-ki, Yamamoto, Takeshi, Takano, Hitoshi, Tsukada, Yayoi, Asai, Kuniya, Miyamoto, Masaaki, Miyauchi, Yasushi, Kodani, Eitaro, Maruyama, Mitsunori, Tanabe, Jun, Shimizu, Wataru
Publicado 2021

Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus

por Mozawa, Kosuke, Kubota, Yoshiaki, Hoshika, Yu, Tara, Shuhei, Tokita, Yukichi, Yodogawa, Kenji, Iwasaki, Yu‐ki, Yamamoto, Takeshi, Takano, Hitoshi, Tsukada, Yayoi, Asai, Kuniya, Miyamoto, Masaaki, Miyauchi, Yasushi, Kodani, Eitaro, Maruyama, Mitsunori, Tanabe, Jun, Shimizu, Wataru
Publicado 2021

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

por Shimizu, Wataru, Kubota, Yoshiaki, Hoshika, Yu, Mozawa, Kosuke, Tara, Shuhei, Tokita, Yukichi, Yodogawa, Kenji, Iwasaki, Yu-ki, Yamamoto, Takeshi, Takano, Hitoshi, Tsukada, Yayoi, Asai, Kuniya, Miyamoto, Masaaki, Miyauchi, Yasushi, Kodani, Eitaro, Ishikawa, Masahiro, Maruyama, Mitsunori, Ogano, Michio, Tanabe, Jun
Publicado 2020